Tricida
$32.979876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$32.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.74 (-2.21%) As of 3:34 PM EST today
-$0.74 (-2.21%) Today
Why Robinhood?
You can buy or sell Tricida and other stocks, options, ETFs, and crypto commission-free!
About TCDA
Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Read More The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.
Employees
76
Headquarters
South San Francisco, California
Founded
2013
Market Cap
1.83B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
172.38K
High Today
$33.98
Low Today
$32.23
Open Price
$33.90
Volume
297.57K
52 Week High
$44.30
52 Week Low
$22.04
Collections
TCDA Earnings
-$1.21
-$0.81
-$0.40
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$1.21 per share
Actual
Available Feb 27, After Hours
People Also Bought
Cronos Group
193,211
$6.06
+0.51%Amarin
16,591
$16.33
-6.69%Viking Therapeutics
39,758
$6.26
-1.73%Catalyst Pharmaceuticals
54,677
$4.68
+3.20%uniQure
676
$53.17
-2.48%Momo
8,670
$28.70
+1.95%Immunomedics
2,408
$16.30
-0.88%Myovant Sciences
5,514
$10.24
-0.58%33,137
$20.21
-3.57%Lyft
56,532
$39.98
-4.40%Magenta Therapeutics
509
$11.47
-4.54%Precision BioSciences
5,220